Top news of the week: 15.12.2021.
Startups
Moderna, Amgen among biotech heavyweights pulling out of JPM conference over Covid concerns
Some of the biggest names in biotech are withdrawing from the J.P. Morgan Healthcare Conference, according to people familiar with the plans.
Biotech and ESG: Does Saving Lives Get You Extra Credit? (And Other Musings)
The growing emphasis on ESG may be a net positive, but how do individual companies allocate resources toward tracking, reporting, or implementing additional practices when those resources ...
This Biotech Company Raised $40 Million To Develop Treatments For ‘Undruggable’ Diseases
Totus Medicines’ has come out of stealth with a technology that could enable it to treat cancers with known targets but no specific drugs—and it’s going into clinical trials next year.
At biotech venture capital firms, collecting ‘consulting fees’ from startups has become widespread
Some of the biggest names in biotech venture capital have charged their startups millions of dollars in “consulting fees” over the past decade.
Science, talent, money: Eir raises $138M VC fund to fill gap in Nordic life science scene
The Nordic life sciences scene is getting an injection of cash. Led by centers such as the Karolinska Institutet and Copenhagen University, the region leads the way in research in the EU by ...
Molly Gibson, Co-Founder of Generate Biomedicines, on Innovating at the Intersection of AI/ML and Biotech
Looking for more life sciences stories? Check us out at Spotify, Apple, Soundcloud, or LinkedIn
Boston Herald: Report: Amid COVID, demand for lab space surges, leading to higher rents
Originally published by the Boston Herald on December 7, 2021 Demand for Boston-area lab space is surging, but the supply is scant, leading to soaring rents, according to a new report. ...
Lilly deepens research ties in China with biotech deal
The collaboration with Regor Therapeutics is another example of large pharma companies' interest in partnering with emerging biotechs from China.